C84.93
Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Mature T/NK-cell lymphomas are a group of rare and aggressive types of lymphomas that originate from T-lymphocytes and natural killer (NK) cells. When these lymphomas involve the intra-abdominal lymph nodes, they can cause significant health issues. The ICD-10 code C84.93 specifically refers to these lymphomas being located in the intra-abdominal region. Understanding this condition, including its causes, symptoms, diagnostic procedures, and potential treatment options, can help patients and caregivers better navigate medical decisions and care planning.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell and NK-cell development Infections such as Epstein-Barr virus (EBV) or other viruses that may trigger abnormal immune responses Immune system disorders or immunodeficiency conditions Environmental factors, including exposure to certain chemicals or toxins Previous radiation therapy or chemotherapy for other cancers
Key Symptoms: Swollen or enlarged lymph nodes in the abdomen, which may cause discomfort or a feeling of fullness Unexplained weight loss and fatigue Persistent fever or night sweats Abdominal pain or tenderness Loss of appetite Unexplained weight loss Possible signs of organ involvement, such as jaundice if the liver is affected
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess lymph node enlargement and check for signs of systemic illness Imaging tests such as computed tomography (CT) scans or positron emission tomography (PET) scans to locate and evaluate the extent of lymph node involvement Biopsy of affected lymph nodes to examine tissue samples under a microscope, confirming the lymphoma type Immunophenotyping and molecular studies to identify specific markers characteristic of T/NK-cell lymphomas Blood tests to evaluate overall health status and organ function
Treatment Protocols: Chemotherapy regimens tailored to target aggressive T/NK-cell lymphomas Targeted therapies that focus on specific markers or genetic features of the cancer cells Radiation therapy, especially if localized symptoms are present or for residual disease after chemotherapy Stem cell transplantation may be considered for eligible patients with relapsed or refractory disease Supportive care to manage symptoms and maintain overall health during treatment
Clinical Advice & FAQs
Billing Guidance
Is C84.93 a billable ICD-10 code?
Yes, C84.93 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.93?
Clinical documentation must specify the nature of Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
